We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
RANDOX LABORATORIES

Download Mobile App




Postsynaptic Density Genes Linked to Multitude of Brain Disorders

By LabMedica International staff writers
Posted on 29 Dec 2010
Print article
The postsynaptic density (PSD), an enigmatic structure located in some brain cell synapses, was analyzed at the proteomic and genomic levels and found to be the source of proteins involved in more than 130 brain diseases.

The PSD is a physical feature of the cytoskeleton found in some synapses of brain cells. PSDs were originally identified by electron microscopy as an electron-dense region at the membrane of a postsynaptic neuron. A PSD's molecular scaffolding is usually composed of L-glutamate neurotransmitter receptors. PSDs also contain cell adhesion molecules and a diverse set of other signaling proteins. PSDs vary in size and composition among brain regions, varying in size from about 250 nm to 500 nm in diameter and 25 nm to 50 nm in thickness, depending on the activity state of the synapse.

In the current study, investigators at the Wellcome Trust Sanger Institute (Hinxton, United Kingdom) isolated the postsynaptic density from human neocortex (hPSD) from patients undergoing brain surgery. The material was examined at both the genomic and proteomic levels. Results published in the December 19, 2010, online edition of the journal Nature Neuroscience revealed that the investigators had identified 1,461 distinct proteins. Mutations among the genes coding for these proteins were linked to 133 neurological and psychiatric diseases.

"We found over 130 brain diseases involve the PSD -- far more than expected," said senior author Dr. Seth Grant, a principle investigator at the Wellcome Trust Sanger Institute. "The human PSD is at center stage of a large range of human diseases affecting millions of people. The conservation of the structure of these proteins suggests that the behaviors governed by the PSD and the diseases associated with them have not changed much over many millions of years."

"We can also see ways to develop new genetic diagnostic tests and help doctors classify the brain diseases," said Dr. Grant.

In an effort to boost PSD research, the investigators have created and released into the public domain a "molecular roadmap" for human synapses showing how the 1,461 proteins and the 130 diseases interconnect.

Related Links:
Wellcome Trust Sanger Institute


Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
Complement 3 (C3) Test
GPP-100 C3 Kit
Gold Member
Fully Automated Cell Density/Viability Analyzer
BioProfile FAST CDV

Print article

Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Molecular Diagnostics

view channel
Image: A network of inflammatory molecules may act as biomarker for risk of future cerebrovascular disease (Photo courtesy of 123RF)

Simple Blood Test Could Enable First Quantitative Assessments for Future Cerebrovascular Disease

Cerebral small vessel disease is a common cause of stroke and cognitive decline, particularly in the elderly. Presently, assessing the risk for cerebral vascular diseases involves using a mix of diagnostic... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: Exosomes can be a promising biomarker for cellular rejection after organ transplant (Photo courtesy of Nicolas Primola/Shutterstock)

Diagnostic Blood Test for Cellular Rejection after Organ Transplant Could Replace Surgical Biopsies

Transplanted organs constantly face the risk of being rejected by the recipient's immune system which differentiates self from non-self using T cells and B cells. T cells are commonly associated with acute... Read more

Microbiology

view channel
Image: The ePlex system has been rebranded as the cobas eplex system (Photo courtesy of Roche)

Enhanced Rapid Syndromic Molecular Diagnostic Solution Detects Broad Range of Infectious Diseases

GenMark Diagnostics (Carlsbad, CA, USA), a member of the Roche Group (Basel, Switzerland), has rebranded its ePlex® system as the cobas eplex system. This rebranding under the globally renowned cobas name... Read more

Pathology

view channel
Image: The Aperio GT 450 DX has received US FDA 510(k) clearance (Photo courtesy of Leica Biosystems)

Use of DICOM Images for Pathology Diagnostics Marks Significant Step towards Standardization

Digital pathology is rapidly becoming a key aspect of modern healthcare, transforming the practice of pathology as laboratories worldwide adopt this advanced technology. Digital pathology systems allow... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.